Clinical Trial Update: Pilot Study for Cyproheptadine in Hospitalized Patient for COVID-19 [Phase 2]

View source ↗

Summary

Pilot Phase 2 trial evaluating cyproheptadine in hospitalized COVID-19 patients; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia
• Viral Pneumonia

Drugs mentioned

• Cyproheptadine (cyproheptadine)

Snippet

Sponsor: Ciusss de L'Est de l'Île de Montréal | Conditions: Viral Pneumonia, COVID-19 Pneumonia | Phase 2 | Status: UNKNOWN